VISION

Precision Medicine Is Revolutionizing Cancer Care. But we’re not there yet.

While immunotherapy has significantly improved patient outcomes, challenges such as variable patient responses and immune-related side effects persist. (Cancers. 2025 Feb 27;17(5):821.)

The tumor is only half of the story.

We don’t know how the patient’s immune system will respond to it.

It's not only cancer

The immune system plays a critical role in all aspects of human health

Cancer

AI-driven SaaS platform with high margins

Autoimmune diseases

Biomarkers & Assays for: Early cancer detection, Patient Therapeutic Response, Novel Drug Targets

Neurodegenerative diseases

Quality Control algorithms, Signal Optimization algorithms, LLM Clinical Data Harmonization, Biomarker Discovery, Predictive analytics

Infectious diseases

ImmunoPD response markers, Mechanism of action & resistance, Biomarkers of response prediction, Discovery of safety biomarkers, Patient selection

Age-related diseases

Support rapid international scale-up strategy, Scalable, decentralized data generation and centralized analytics

AI is revolutionizing cancer care

Our AI-enabled technology platform is at the forefront of this revolution.

The integration of artificial intelligence (AI) into oncology promises to revolutionize cancer care.

Nature Cancer. 2025;6(7):Review article.